600
Participants
Start Date
August 31, 2011
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
Research Site, Chita
Research Site, Ivanovo
Research Site, Krasnodar
Research Site, Moscow
Clinical Site, Novosibirsk
Clinical Site, S-Petersburg
Research Site, Samara
Research Site, Yekaterinburg
Lead Sponsor
AstraZeneca
INDUSTRY